717 related articles for article (PubMed ID: 16520435)
1. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
2. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
4. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
Guastella AJ; Richardson R; Lovibond PF; Rapee RM; Gaston JE; Mitchell P; Dadds MR
Biol Psychiatry; 2008 Mar; 63(6):544-9. PubMed ID: 18179785
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
9. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
10. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.
Guastella AJ; Howard AL; Dadds MR; Mitchell P; Carson DS
Psychoneuroendocrinology; 2009 Jul; 34(6):917-23. PubMed ID: 19246160
[TBL] [Abstract][Full Text] [Related]
13. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
14. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
Davis M; Ressler K; Rothbaum BO; Richardson R
Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
[TBL] [Abstract][Full Text] [Related]
15. Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.
Berry AC; Rosenfield D; Smits JA
Depress Anxiety; 2009; 26(1):22-7. PubMed ID: 18781661
[TBL] [Abstract][Full Text] [Related]
16. Psychotherapy in the overall management strategy for social anxiety disorder.
Shear MK; Beidel DC
J Clin Psychiatry; 1998; 59 Suppl 17():39-46. PubMed ID: 9811429
[TBL] [Abstract][Full Text] [Related]
17. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM
J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151
[TBL] [Abstract][Full Text] [Related]
18. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput clinical assay for testing drug facilitation of exposure therapy.
Rodebaugh TL; Levinson CA; Lenze EJ
Depress Anxiety; 2013 Jul; 30(7):631-7. PubMed ID: 23283838
[TBL] [Abstract][Full Text] [Related]
20. Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia?
Borgeat F; Stankovic M; Khazaal Y; Rouget BW; Baumann MC; Riquier F; O'Connor K; Jermann F; Zullino D; Bondolfi G
J Nerv Ment Dis; 2009 Jul; 197(7):507-13. PubMed ID: 19597358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
